C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/24 (2006.01) A61K 31/44 (2006.01) A61P 25/00 (2006.01) C07C 13/00 (2006.01) C07D 205/04 (2006.01) C07D 231/24 (2006.01) C07D 239/30 (2006.01) C07D 403/12 (2006.01)
Patent
CA 2630039
The present invention relates to compounds of formula (I); and pharmaceutically acceptable salts thereof and individual enantiomers and diastereomers thereof, as GIyTl inhibitors for treating neurological and psychiatric disorders.
La présente invention concerne des composés de formule I : ,R5 R1 N Il > ^\C / A^ R2 \ / N (A)n, v H / / \ Rb « T Ra ^SO2R3 (I) ainsi que des sels de qualité pharmaceutique desdits composés et des énantiomères et des diastéréoisomères purs desdits composés, en tant qu'inhibiteurs de GlyT1, pour le traitement de troubles neurologiques et psychiatriques.
Blackaby Wesley Peter
Lewis Richard Thomas
Naylor Elizabeth Mary
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Azetidine derivatives as glyt1 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azetidine derivatives as glyt1 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azetidine derivatives as glyt1 inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2048856